A tick-borne encephalitis virus vaccine based on the European prototype strain induces broadly reactive cross-neutralizing antibodies in humans.

Authors:
Address: Global Research and Development, Baxter BioScience, Vienna, Austria.
Journal:

Publication:

abstract

After vaccination of humans with tick-borne encephalitis virus (TBEV) vaccine, the extent of cross-neutralization between viruses of the European, Far Eastern, and Siberian subtypes of TBEV and Omsk hemorrhagic fever virus (OHFV) was analyzed. Hybrid viruses that encode the TBEV surface proteins for representative viruses within all subtypes, and OHFV, were constructed using the West Nile virus (WNV) backbone as vector. These viruses allow for unbiased head-to-head comparison in neutralization assays because they exhibit the antigenic characteristics of the TBEV strains from which the surface proteins were derived and showed equivalent biologic properties in cell culture. Human serum samples derived from a TBEV vaccine trial were analyzed and revealed comparable neutralizing antibody titers against European, Far Eastern, and Siberian subtype viruses, indicating equally potent cross-protection against these TBEV strains and a somewhat reduced but still protective neutralization capacity against more distantly related viruses, such as OHFV.

Related Articles
Flavivirus-induced antibody cross-reactivity.
J Gen Virol. 2011
Flavivirus-induced antibody cross-reactivity.
Mansfield KL, Horton DL, Johnson N, Li L, Barrett AD, Smith DJ, Galbraith SE, Solomon T, Fooks AR. J Gen Virol. 2011 Dec; 92(Pt 12):2821-9. Epub 2011 Sep 7.
Quantitative comparison of the cross-protection induced by tick-borne encephalitis virus vaccines based on European and Far Eastern virus subtypes.
Vaccine. 2012
Quantitative comparison of the cross-protection induced by tick-borne encephalitis virus vaccines based on European and Far Eastern virus subtypes.
Fritz R, Orlinger KK, Hofmeister Y, Janecki K, Traweger A, Perez-Burgos L, Barrett PN, Kreil TR. Vaccine. 2012 Feb 1; 30(6):1165-9. Epub 2011 Dec 14.
Tick-borne Langat/mosquito-borne dengue flavivirus chimera, a candidate live attenuated vaccine for protection against disease caused by members of the tick-borne encephalitis virus complex: evaluation in rhesus monkeys and in mosquitoes.
J Virol. 2001
Tick-borne Langat/mosquito-borne dengue flavivirus chimera, a candidate live attenuated vaccine for protection against disease caused by members of the tick-borne encephalitis virus complex: evaluation in rhesus monkeys and in mosquitoes.
Pletnev AG, Bray M, Hanley KA, Speicher J, Elkins R. J Virol. 2001 Sep; 75(17):8259-67.
Review Tick-borne encephalitis.
Antiviral Res. 2003
Review Tick-borne encephalitis.
Gritsun TS, Lashkevich VA, Gould EA. Antiviral Res. 2003 Jan; 57(1-2):129-46.
Review [Molecular genetic characteristics of tick-borne encephalitis virus].
Vopr Virusol. 2007
Review [Molecular genetic characteristics of tick-borne encephalitis virus].
Loktev VB, Ternovoĭ VA, Netesov SV. Vopr Virusol. 2007 Sep-Oct; 52(5):10-6.

To top • Home

TraveldoctorOnline 2001 • Disclaimer • webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.